Toxoplasma gondii in dromedary camels () in Egypt: a comparative seroepidemiological study in Upper and Lower Egypt.

Fiche publication

Date publication

janvier 2025

Journal

Frontiers in veterinary science

Auteurs

Membres identifiés du Cancéropôle Est :
Pr VILLENA Isabelle

Tous les auteurs :
Elmahallawy EK, Elbarbary NK, Cano-Terriza D, Fajardo T, Albalawi NO, Jiménez-Martín D, Ghallab MMI, Gareh A, Ras R, Villena I, Sadek SAS, AlQadeeb H, Alzaylaee H, Almería S, García-Bocanegra I

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39902335

Résumé

Toxoplasmosis remains a prevalent parasitic zoonosis worldwide, raising public health concerns. The global information available regarding the role of camels in the epidemiology of is still limited. This study aimed to assess the seroprevalence of in dromedary camels () from northern and southern Egypt. A total of 513 serum samples were obtained from camels across Cairo (Lower Egypt) and Aswan (Upper Egypt) governorates. The Modified Agglutination Test (MAT) was performed to screen for anti- antibodies. The overall seroprevalence was 13.84% (71/513; 95CI%:10.85-16.83). The bivariate analysis showed that animals aged 4-8 years (13.84%, 36/260) and older than 8 years (18.45%, 31/168) showed significantly higher seropositivity compared to those young individuals (≤ 4 years old) ( = 0.011). Additionally, the multiple logistic regression analysis highlighted the geographic region as a potential risk factor for exposure. Thus, camels from Lower Egypt had significantly higher seroprevalence of (19.92%, 51/256) compared to those from Upper Egypt (7.78%; 20/257;  < 0.001; odds ratio [OR] = 2.94; 95% CI: 1.70-5.10). Our results provide evidence of moderate, widespread, and heterogeneous spatial distribution of among camel populations in Egypt, which might have important implications for animal and public health in that country. Surveillance and control programs should be implemented to reduce the risk of exposure of in camels.